Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: Results of the first 100 cases

European Journal of Surgical Oncology

Volumn 35, Issue 7, 2009, Pages 751-756

  Bastide, C ^a   Brenot Rossi, I ^b   Garcia, S ^a   Rossi, D ^a  

^a HÔPITAL NORD   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

Prostate cancer; Prostatectomy; Sentinel lymph nodes

Indexed keywords

RADIOISOTOPE;

ARTICLE; BIOPSY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; GLEASON SCORE; HUMAN; HUMAN TISSUE; INTERNAL ILIAC ARTERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RECUMBENCY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY;

EID: 67349140936     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.04.007     Document Type: Article

References (26)

1. Hacker A., Jeschke S., Leeb K., et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 176 (2006) 2014-2018
2. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., Hulsbergen van de Kaa C., et al. Non invasive detection of clinically occult lymph node metastases in prostate cancer. N Engl J Med 19 (2003) 2491-2499
3. Messing E.M., Manola J., Sarosdy M., Wilding G., Crawford E.D., and Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
4. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
5. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
6. Schumacher M.C., Burkhard F.C., Thalmann G.N., Fleischmann A., and Studer U.E. Is pelvic lymph node dissection necessary in patients with a serum PSA <10 ng/ml undergoing radical prostatectomy for prostate cancer?. Eur Urol 50 (2006) 272-279
7. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-147
8. Stone N.N., Stock R.G., and Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol 158 (1997) 1891-1894
9. Briganti A., Chun F.K., Salonia A., et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50 (2006) 1006-1013
10. Wawroschek F., Vogt H., Weckermann D., Wagner T., Hamm M., and Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166 (2001) 1715-1719
11. American Joint Committee on Cancer. Cancer staging handbook: TNM classification of malignant tumors. 6th ed. (2002), Springer, Berlin Heidelberg New York
12. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 95 (2002) 281-286
13. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., and Walsh P.C. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840-1844
14. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
15. Ghavamian R., Bergstralh E.J., Blute M.L., Slezak J., and Zincke H. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol 161 (1999) 1223-1227
16. Partin A.W., Mangold L.A., Lamm D.M., Walsh P.C., Epstein J.I., and Pearson J.D. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843-848
17. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 98 (2006) 788-793
18. Weckermann D., Dorn R., Holl G., Wagner T., and Harzmann R. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51 (2007) 1549-1556
19. Burkhard F.C., Bader P., Schneider E., Markwalder R., and Studer U.E. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 42 (2002) 84-90
20. Corvin S., Schilling D., Eichhorn K., et al. Laparoscopic sentinel lymph node dissection-a novel technique for the staging of prostate cancer. Eur Urol 49 (2006) 280-285
21. Jeschke S., Beri A., Grüll M., Ziegerhofer J., Prammer P., Leeb K., Sega W., and Janetschek G. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 53 (2008) 126-133
22. Weckermann D., Dorn R., Trefz M., Wagner T., Wawroschek F., and Harzmann R. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 177 (2007) 916-920
23. Fukuda M., Egawa M., Imao T., Takashima H., Yokoyama K., and Namiki M. Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer. J Urol 177 (2007) 1313-1317
24. Cheng L., Zincke H., Blute M.L., Bergstralh E.J., Scherer B., and Bostwick D.G. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 (2001) 66-73
25. Weckermann D., Goppelt M., Dorn R., Wawroschek F., and Harzmann R. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/ml and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 97 (2006) 1173-1178
26. Takashima H., Egawa M., Imao T., et al. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171 (2004) 2268-2271